» Articles » PMID: 22293986

Importance of T Lymphocytes in Brain Injury, Immunodeficiency, and Recovery After Cerebral Ischemia

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Following an ischemic stroke, T lymphocytes become activated, infiltrate the brain, and appear to release cytokines and reactive oxygen species to contribute to early inflammation and brain injury. However, some subsets of T lymphocytes may be beneficial even in the early stages after a stroke, and recent evidence suggests that T lymphocytes can also contribute to the repair and regeneration of the brain at later stages. In the hours to days after stroke, T-lymphocyte numbers are then reduced in the blood and in secondary lymphoid organs as part of a 'stroke-induced immunodeficiency syndrome,' which is mediated by hyperactivity of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis, resulting in increased risk of infectious complications. Whether or not poststroke T-lymphocyte activation occurs via an antigen-independent process, as opposed to a classical antigen-dependent process, is still controversial. Although considerable recent progress has been made, a better understanding of the roles of the different T-lymphocyte subpopulations and their temporal profile of damage versus repair will help to clarify whether T-lymphocyte targeting may be a viable poststroke therapy for clinical use.

Citing Articles

Genome-wide KAS-Seq mapping of leukocytes in ischemia-reperfusion model reveals IL7R as a potential therapeutic target for ischemia-reperfusion injury.

Zhang L, Duolikun M, Chen H, Wang Z, Li X, Xiao H Sci Rep. 2025; 15(1):6165.

PMID: 39979392 PMC: 11842730. DOI: 10.1038/s41598-025-90457-7.


Regulatory T Cell- and Natural Killer Cell-Mediated Inflammation, Cerebral Vasospasm, and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage-A Systematic Review and Meta-Analysis Approach.

Pfnur A, Mayer B, Dorfer L, Tumani H, Spitzer D, Huber-Lang M Int J Mol Sci. 2025; 26(3).

PMID: 39941044 PMC: 11818301. DOI: 10.3390/ijms26031276.


Association of the Systemic Inflammation Response Index with Functional Outcome in Acute Large Vessel Occlusion Stroke Patients Receiving Mechanical Thrombectomy.

Wu W, Zhang Y, Qu X, Zhang Z J Inflamm Res. 2024; 17:11057-11072.

PMID: 39697791 PMC: 11654214. DOI: 10.2147/JIR.S497754.


Enhancing Th17 cells drainage through meningeal lymphatic vessels alleviate neuroinflammation after subarachnoid hemorrhage.

Gao D, Zou B, Zhu K, Bi S, Zhang W, Yang X J Neuroinflammation. 2024; 21(1):269.

PMID: 39428510 PMC: 11492769. DOI: 10.1186/s12974-024-03252-y.


Patients with Severe Trauma Having an Injury Severity Score of 24 and above Develop Nutritional Disorders.

Mizuochi M, Yamaguchi J, Chiba N, Kinoshita K Diagnostics (Basel). 2024; 14(12).

PMID: 38928722 PMC: 11202517. DOI: 10.3390/diagnostics14121307.


References
1.
Iadecola C, Sugimoto K, Niwa K, Kazama K, Ross M . Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice. J Cereb Blood Flow Metab. 2001; 21(12):1436-41. DOI: 10.1097/00004647-200112000-00008. View

2.
Bochelen D, Rudin M, Sauter A . Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther. 1999; 288(2):653-9. View

3.
Chen H, Song Y, Chan P . Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. J Cereb Blood Flow Metab. 2009; 29(7):1262-72. PMC: 2733333. DOI: 10.1038/jcbfm.2009.47. View

4.
Kleinschnitz C, De Meyer S, Schwarz T, Austinat M, Vanhoorelbeke K, Nieswandt B . Deficiency of von Willebrand factor protects mice from ischemic stroke. Blood. 2009; 113(15):3600-3. DOI: 10.1182/blood-2008-09-180695. View

5.
Dirnagl U, Iadecola C, Moskowitz M . Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999; 22(9):391-7. DOI: 10.1016/s0166-2236(99)01401-0. View